Global Biotech Perspectives: Takeaways from My Recent Travels to Asia
Thoughts from Geoff Meyerson This past two weeks I had the privilege of visiting Japan and China, hosted by Locust […]
Uncategorized
News
Bausch Health to Acquire DURECT Corporation
LOCUST WALK NEWS Bausch Health to Acquire DURECT Corporation DURECT’s lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough
Uncategorized
Episode 29: Asia’s 2025 Q2 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 7:34 — 17.3MB)
Subscribe: Apple Podcasts | Spotify | RSS
During the Asia-focused Episode 29 of Biotalk, Geoff shares insights into key trends and developments shaping the biotech landscapes in
Uncategorized
Biotalk Episode 28: 2025 Q2 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 17:28 — 40.0MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 28 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q2 Report: Global Trends in Biopharma
Insight, Locust Walk Insights, Market Conditions, Market Trends, Quarterly Reports
2025 Q2 Report: Global Trends in Biopharma Transactions
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2025 Q2 Report applies the latest data to analyze the current landscape in life sciences deals.
Uncategorized
Episode 27: Inside the Biopharma Market: 2025 Outlook & Emerging Trends
Podcast: Play in new window | Download (Duration: 7:47 — 17.8MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 27 of Biotalk, Geoff Meyerson, CEO of Locust Walk, steps back to examine the macro forces shaping the
Uncategorized
Episode 26: Asia’s 2025 Q1 Report: Global Trends in Biopharma Transactions
During the Asia-focused Episode 26 of Biotalk, Geoff Meyerson, CEO of Locust Walk, shares fresh insights from Japan, China, and Korea,
Uncategorized
Biotalk Episode 25: 2025 Q1 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 13:17 — 30.4MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 25 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q1 Report: Global Trends in Biopharma
Insight, Locust Walk Insights, Market Conditions, Market Trends, Quarterly Reports
2025 Q1 Report: Global Trends in Biopharma Transactions
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2025 Q1 Report applies the latest data to analyze the current landscape in life sciences deals.
Insight, Locust Walk Insights, Market Trends, Quarterly Reports, White Papers
China Supermarket: Is the Value for Money Due to Global Development Expertise or Superior Negotiation?
Locust Walk analyzed the evolving landscape of China’s biotech out-licensing market and its impact on global dealmaking.